Isolation of <Glu-Gly-Leu-Arg-Trp-NH2 (Antho-RWamide II), a novel neuropeptide from sea anemones  by Graff, D. & Grimmelikhuijzen, C.J.P.
Volume 239, number 1, 137-140 FEB 06424 October 1988 
Isolation of (Glu-Gly-Leu-Arg-Trp-NH2 (Antho-RWamide II), a 
novel neuropeptide from sea anemones 
D. Graff and C.J.P. Gtimmelikhuijzen 
Center for Molecular Neurobiology, University Hospital Eppendorf, 2000 Hamburg 20 and Center for Molecular Biology, 
University of Heidelberg, 6900 Heidelberg, FRG 
Received 16 August 1988 
Using a radioimmunoassay for the peptide sequence Arg-Phe-NH* (RFamide), a novel peptide has been purified from 
acetic acid extracts of the sea anemone Anthopleuru elegantissimo. This peptide has the structure (Glu-Gly-Leu-Arg-Trp- 
NH?, and was named Antho-RWamide II. Antho-RWamide 11 is a neuropeptide. Its structure is closely related to an 
earlier characterized neuropeptide from Anthopleura (Glu-Ser-Leu-Arg-Trp-NH2 (Antho-RWamide I). 
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1. INTRODUCTION 
Coelenterates have the simplest nervous systems 
of the animal kingdom. In these primitive nervous 
systems peptides play an important role. In earlier 
papers we reported on the sequence of two novel 
neuropeptides from the sea anemone Anthopleura 
elegantissima, <Glu-Gly-Arg-Phe-NH2 (Antho- 
RFamide) and <Glu-Ser-Leu-Arg-Trp-NH2 [ 1,2]. 
These peptides have excitatory actions on muscles 
and neuronal systems of sea anemones, suggesting 
that they might be neurotransmitters ([3]; 
McFarlane, Graff and Grimmelikhuijzen, un- 
published). In the present paper we describe the 
isolation and sequencing of a third neuropeptide 
from sea anemones. 
2. MATERIALS AND METHODS 
A. elegantissima were obtained from Biomarine Laboratories, 
(Venice, USA). The fotlowing procedures and techniques have 
been described before: acetic acid extraction of sea anemones, 
the desalting procedure using Sep-pak C-18 cartridges and the 
cation-exchange chromatography using CM-Sephadex C-25 
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[1,2]. HPLC was carried out using a Shimadzu LC-6A system. 
The HPLC columns were described earlier [l]. The amino acid 
composition of the peptide was determined by hydrolysis (6 N 
HCl, overnight, 1 lS”C), subsequent dansylation and separation 
of the dansylation products on 2.5 x 2.5 cm polyamide sheets 
[1,4,5]. Sequencing was carried out with the 4-N,N’-di- 
methylaminoazobenzene 4’ -isothiocyanate (DABITC) method 
[6]. Enzymatic removal of pyroglutamate from a blocked pep- 
tide was performed by digestion with pyroglutamate aminopep- 
tidase following a protocol described in [I]. Trypsin digestion 
was carried out as in [2]. The details of the Arg-Phe-NH2 
(RFamide) radioimmunoassay are given in [l]. In short, this 
radioimmunoassay only recognizes peptides which contain a 
carboxy-terminal amidation as well as an uncharged aromatic 
or aliphatic amino acid in the carboxy-terminal position, 
preceded by Arg or Lys [l]. Synthetic <Glu-Gly-Leu-Arg-Trp- 
NH2 was prepared as a customer synthesis by Bachem (Buben- 
dorf, Switzerland). 
3. RESULTS 
In a former article we prepared an acetic acid ex- 
tract of 150 g (wet weight) A. elegantissima [2]. 
This extract was desalted using Sep-pak and 
purified by cation-exchange chromatography [2]. 
Subsequent HPLC using a Spherisorb ODS-2 col- 
umn and a 20 min gradient of lo-60% acetonitrile 
in 0.1% trifluoroacetic acid (TFA) revealed three 
fractions which were immunoreactive in a radioim- 
munoassay for the sequence RFamide [2]. This is 
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Fig. 1. HPLC of an acetic acid extract of 150 g (wet weight) 
Anthopleura elegantissima. This extract is the same as the one 
which was prepared, purified and desalted in [2]. The vertical 
bar is 1.0 AA at 215 nm. (a) This is the same figure as fig.2a 
from [2]. Of a total amount of 200 nmol RFamide equivalents 
(400 J), 50 nmol(lO0 ~1) was injected. The column (Spherisorb 
ODS-2, 5 pm particle size, 80 A pore diameter; dimensions: 4 x 
250 mm) was equilibrated with 10% acetonitrile in 0.1% TFA. 
After injection of the sample, a linear gradient of lo-60% 
acetonitrile in 0.1% TFA was started (20 min; 1 ml/min). 
Immunoreactive components (arrows) were eluted at 7.9- 
9.0 min (30 nmol RFamide equivalents), at 10.3-l 1.9 min 
(13 nmol) and at 11.9-13.3 min (1 nmol). (b) HPLC of the 
combined 11.9-13.3 min fractions of a. Of a total amount of 
4 nmol RFamide equivalents (3OOyl), 1.3 nmol (lOO$) was 
injected. The column was Partisil ODS-3, 5 Frn, 60 A, 4 x 
250 mm. After equilibration with 10% acetonitrile in 0.1% 
TFA, the sample was injected and a gradient of lo-60% 
acetonitrile in 0.1% TFA was started (20 min; 1 mUmin). 
Immunoreactive peaks (arrows) appeared at 10.500- 
10.890 min (800 pmol RFamide equivalents) and at 10.890- 
11.160 min (200 pmol). (c) HPLC of the combined 10.890- 
11.160 min fractions of b. Of a total amount of 600 pmol 
RFamide equivalents (40 ,~l), 300 pmol(20 ,uI) was injected. The 
column was Nucleosil C-18 (5 pm, 120 A, 4 x 250 mm). After 
equilibration with 10% acetonitrile in 0.1% TFA, the sample 
was injected and a gradient of lo-35% acetonitrile in 0.1% 
TFA was started (20 min; 1 ml/min). Several peaks appeared of 
which the major one (15.107 min; arrow) was immunoreactive 
(200 pmol). Realize that 1 pmol of RFamide equivalents, as 
measured in our radioimmunoassay, might be more than 
1 pmol of pure peptide [l]. 
138 
Volume 239, number 1 FEBS LETTERS October 1988 
shown in fig. la. The first immunoreactive fraction 
(7.9-9.0 min) was eluted at the position of Antho- 
RFamide (<Glu-Gly-Arg-Phe-NHz). From the se- 
cond fraction (10.3-l 1.9 min), <Glu-Ser-Leu- 
Arg-Trp-NHz was isolated [2]. The third compo- 
nent (11.9-13.3 min) was not characterized in our 
former paper [2]. This material was now further 
purified by HPLC using a column containing Par- 
tisil ODS-3 and a 20 min gradient of lo-60% 
acetonitrile in 0.1% TFA (fig.lb). Two im- 
munoreactive peaks were eluted, one appearing at 
10.50-10.89 min and another at 10.89-11.16 min. 
An aliquot of the first peak (100 pmol RFamide 
equivalents; realize that the absolute amount of 
peptide might be higher, cf. fig.2 of [l]) was 
hydrolyzed with HCl and subsequently dansylated. 
This hydrolysate showed the same amino acid 
composition as a hydrolysate of <Glu-Ser-Leu- 
Arg-Trp-NH2 (Trp is always destroyed under these 
conditions). The 10.50-10.89 min component is 
therefore most likely <Glu-Ser-Leu-Arg-Trp-NH2 
and was not further investigated. The 
10.89-l 1.16 min component was purified by 
HPLC using Nucleosil C-18 and a 20 min gradient 
of lo-35% acetonitrile in O.lcr/o TFA (fig.lc). 
Several peaks appeared of which the major one 
(15,107 min) was immunoreactive. 
This major component, although not totally 
pure, was analyzed for its amino acid composition 
(20 pmol RFamide equivalents). This revealed 
Glu, Gly, Leu and Arg. An end group determina- 
tion of the intact peptide (10 pmol RFamide 
equivalents), using the DABITC method [6], show- 
ed that no reactive amino-terminal amino acid was 
present. As Glu was one of the amino acids in the 
hydrolysate, the amino-terminus could be <Glu. 
To investigate this, intact peptide (80 pmol 
RFamide equivalents) was incubated with 6 mU 
pyroglutamate aminopeptidase. After this diges- 
tion, the sample was purified by HPLC using Par- 
tisil ODS-3 and a 20 min gradient of lo-35070 
acetonitrile in 0.1% TFA. Two immunoreactive 
components appeared during this chromato- 
graphy: one at 15.308 min, which is the position of 
intact peptide (cf. table 1) and another, new com- 
ponent at 13.900 min (not shown). An aliquot of 
this new material (20 pmol RFamide equivalents) 
was hydrolyzed and dansylated. Analysis showed 
Gly, Leu and Arg, whereas Glu was failing. 
Therefore, the amino-terminus of the intact pep- 
tide is most likely cGlu and the new 13.900 min 
component is the carboxy-terminal fragment of 
the intact peptide after removal of <Glu. The 
13.900 min component was sequenced using the 
DABITC method. This yielded the sequence Gly- 
Leu-Arg with no amino acids following Arg using 
the extraction procedures of Chang et al. [6]. 
Because such a sequence is not recognized in our 
RFamide radioimmunoassay (see section 2), and 
because aromatic or aliphatic amino acid amides 
cannot be detected by the DABITC method of 
Chang [6], we supposed that an amino acid amide 
follows Arg. This was investigated by incubating 
intact peptide (20 pmol RFamide equivalents) with 
Table 1 
Comparison by HPLC of the chromatographic behaviour of the natural Anthopleura peptide and 
synthetic <Glu-Gly-Leu-Arg-Trp-NH2 
Column material Gradient of Retention time 
acetonitrile (min) of the 
in 0.1% TFA natural peptide 
Spherisorb ODS-2, 5 pm, 80 A 
Nucleosil C-18, 5 pm, 120 A 
Nucleosil C-18, 5 pm, 300 A 
Partisil ODS-3, 5 pm, 60 A 
Spherisorb C-8, 5 pm, 80 A 
Nucleosil propyl-nitrile, 
7flm, 300A 
lo-35% (20 min) 17.532 17.547 
lo-35% (20 min) 15.042 15.032 
lo-35% (20 min) 13.488 13.497 
lo-35% (20 min) 15.457 15.450 
lo-35% (20 min) 17.028 17.038 
lo-10% (15 min) 6.417 6.408 
Retention time 
(min) of 
<Glu-Gly-Leu- 
Arg-Trp-NH2 
Column materials with different ligands and pore diameters were used. The dimensions of the 
columns were 4 x 250 mm. The retention-time variability of the HPLC system was + 1% 
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Sepharose-bound trypsin. Dansylation of the 
digestion products and analysis on polyamide 
sheets showed a prominent spot of Trp-NHz. 
From all these data, the complete sequence of 
the intact peptide has to be <Glu-Gly-Leu-Arg- 
Trp-NH2. This peptide was synthesized by Bachem 
(Bubendorf, Switzerland). The chromatographic 
behaviour of the natural Anthopleura peptide was 
subsequently compared with that of synthetic 
<Glu-Gly-Leu-Arg-Trp-NH2 using HPLC and six 
different HPLC columns. Table 1 shows that the 
natural and synthetic peptide were always eluted at 
the same retention times. This confirmed the struc- 
ture of the Anthopleura peptide. 
4. DISCUSSION 
Two neuropeptides have recently been isolated 
from the sea anemone Anthopleura elegantissima: 
<Glu-Gly-Arg-Phe-NH2 (Antho-RFamide) and 
<Glu-Ser-Leu-Arg-Trp-NH2 [ 1,2]. The novel pep- 
tide that we describe in the present paper is closely 
related to <Glu-Ser-Leu-Arg-Trp-NH2 and only 
differs from this by a Gly in position 2. This sug- 
gests that the DNA sequences coding for the two 
peptides have a common evolutionary origin. 
In analogy to the name Antho-RFamide 
(originating from Anthopleura RFamide peptide), 
we would like to call <Glu-Ser-Leu-Arg-Trp-NH2 
Antho-RWamide I, and <Glu-Gly-Leu-Arg-Trp- 
NH2 Antho-RWamide II. Using antisera to the se- 
quence Arg-Trp-NHz, we have found that Arg- 
Trp-NH2 immunoreactivity was located in 
neurones of sea anemones and that non-neuronal 
cells were not stained [2]. This shows that both 
Antho-RWamide I and II are neuropeptides. 
Recent experiments have shown that Antho- 
RWamide I is biologically active: low concentra- 
tions (lO-8-lO-7 M) of neuropeptide induce con- 
tractions in endodermal muscles of sea anemones 
(McFarlane, Graff and Grimmelikhuijzen, un- 
published). The action of Antho-RWamide II has 
not been investigated so far. One can assume, 
however, that also this neuropeptide plays a role in 
neurotransmission. 
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